文献速递关节外科

全膝关节置换术后关节腔内注射皮质类固醇:是否有效?

Intra-articular Corticosteroid Injection Following Total Knee Arthroplasty: Is It Effective?
PubMed 文献 · J Arthroplasty · 2018-11-03

该回顾性病历回顾纳入2015至2016年由单一外科医生行初次全膝关节置换术后接受关节腔内皮质类固醇注射的患者,问卷应答率70.1%。129例应答者中84.1%报告注射后膝关节有轻度至明显改善,76.6%报告疼痛减轻,注射后1年内无患者发生假体周围关节感染。作者认为部分全膝关节置换术后患者可能从皮质类固醇注射中获益,但仅应在临床、影像学和实验室检查排除不太可能长期改善的情况后进行。

要点

  • 129例应答者中84.1%报告注射后膝关节有轻度至明显改善。
  • 76.6%报告疼痛减轻,57.9%报告活动度增加,65.4%报告长期肿胀减轻。
  • 56.1%患者改善持续超过1个月,注射后1年内无假体周围关节感染发生。

核心结论

  • 作者认为部分全膝关节置换术后患者可能从关节腔内皮质类固醇注射中获益。
  • 作者认为该操作仅应在临床、影像学和实验室检查排除不太可能长期从皮质类固醇注射中改善的情况后进行。

研究设计与样本

  • 回顾性病历回顾,纳入2015至2016年由单一外科医生行初次全膝关节置换术后随后接受置换膝关节腔内皮质类固醇注射的患者。
  • 患者在注射前接受临床检查、排除感染的实验室分析和影像学评估,并记录患者变量,通过患者满意度调查评估注射疗效,调查应答率为70.1%。

主要发现

  • 129例应答者中82.9%记得该次注射。
  • 从初次关节置换到注射的时间为中位5.3个月(四分位距2.1-23.4),30.8%患者接受超过1次注射(范围1-5次)。
  • 总体76.6%报告疼痛减轻,57.9%报告活动度增加,65.4%报告长期肿胀减轻。
  • 56.1%患者改善持续超过1个月,总体84.1%报告注射后膝关节有轻度至明显改善。
  • 注射后1年内无患者发生假体周围关节感染。

临床怎么用

  • 作者认为部分全膝关节置换术后患者可能从关节腔内皮质类固醇注射中获益。
  • 作者认为该操作仅应在临床、影像学和实验室检查排除不太可能长期从皮质类固醇注射中改善的情况后进行。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total knee arthroplasty (TKA) for the majority of patients with severe knee osteoarthritis provides relief of symptoms and improved function. However, there remains a subset of dissatisfied patients despite an unremarkable workup. A corticosteroid injection (CSI) is a commonly used nonsurgical treatment for painful knee osteoarthritis but its efficacy in a replaced knee remains unknown. METHODS: A retrospective chart review identified primary TKA patients who subsequently received a CSI into a replaced knee from 2015 to 2016 by a single surgeon. Patients receiving a CSI underwent clinical examination, laboratory analysis to rule out infection, and radiographic evaluation before CSI. Patient variables were recorded and a patient satisfaction survey assessed the efficacy of the injection. The survey response rate was 70.1%. RESULTS: Of the 129 responders, 82.9% remembered the injection. The average time from index arthroplasty to injection was median 5.3 months (interquartile range, 2.1-23.4) and 30.8% of patients received more than 1 injection (range, 1-5). Overall, 76.6% reported decreased pain, 57.9% reported increased motion, and 65.4% reported long-term decreased swelling. Improvement lasted greater than 1 month for 56.1% of patients, and overall 84.1% reported improvement (slight to great) in the knee following CSI. No patient developed a periprosthetic joint infection (PJI) within 1 year of injection. CONCLUSION: This study suggests that certain patients following TKA may benefit from a CSI. However, this should only be performed once clinical, radiographic, and laboratory examination has ruled out conditions unlikely to improve long term from a CSI.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Klement MR, Luzzi AJ, Siddiqi A, et al. Intra-articular Corticosteroid Injection Following Total Knee Arthroplasty: Is It Effective? J Arthroplasty. 2018. PMID: 30477967. doi:10.1016/j.arth.2018.10.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。